Daniel K. Spiegelman, Director at MYRIAD GENETICS INC (MYGN), sold 6,278 shares at $30.52 ($192K) on 2021-06-17, disclosed to the SEC on 2021-06-17.
Open-market sale of $192k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.52 | 3,139 | $96K | 50.0% |
| 2 | $30.52 | 3,139 | $96K | 50.0% |
| Total | $30.52 avg | 6,278 | $192K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |
| BMRN | SELL | 2019-04-03 | $1.2M | — | Filing → |